Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We are retaining our Outperform recommendation on leading fertilizer company Agrium Inc. ( AGU - Analyst Report ) following its strong second-quarter 2012 results. Adjusted earnings of $5.43 per share topped the Zacks Consensus Estimate of $5.36, while profit surged 20% year over year to a record level.
Revenues spiked roughly 10% year over year to roughly $6.8 billion on the back of strong demand for all crop input products. Sales beat the Zacks Consensus Estimate of $6.5 billion.
The company's core retail segment posted sales of $5.2 billion, a year-over-year surge of 12%. Crop nutrient sales jumped 12% to $2.4 billion as farmers took advantage of favorable crop prices and increased nutrient purchase. Revenues from the wholesale segment marginally rose to $1.7 billion while sales from the Advanced Technologies division climbed 13% to $178 million.
The company expects crop yields to be lower in 2012 owing to the severe drought in the U.S., resulting in high grain prices. High crop prices (especially for corn) and tight grain inventories are expected to create huge demand for its crop nutrients.
Agrium stands to benefit from skyrocketing crop prices and overall strong fundamentals for the agriculture and crop input market. The company is poised to gain from the U.S. Midwest drought in the remainder of 2012.
Moreover, Agrium follows a strategy to grow along the value chain through a combination of acquisitions and organic development. The acquisition of AWB has expanded the company's retail division and provided access to the growing Southeast Asia market.
Agrium recently said that it has no plans of splitting its retail operation. The company also noted that it will continue pursuing its business strategy of generating strong results while boosting shareholders' returns.
We expect strong global demand for fertilizers and seeds to boost Agrium's results in 2012. However, the global macroeconomic situation presents some risks that can potentially impact agricultural markets.
Agrium, which competes with CF Industries Holdings Inc. ( CF - Analyst Report ) and Potash Corp. of Saskatchewan Inc. ( POT - Analyst Report ) , maintains a Zacks #2 Rank, implying a short-term (1 to 3 months) Buy rating.
Read the full reports :
Analyst Report on POT
Analyst Report on CF
Analyst Report on AGU